Bluzin Pharmaceuticals Private Limited
About Bluzin Pharmaceuticals Private Limited
Data last updated:
Bluzin Pharmaceuticals Private Limited is a private limited company based in Mathura, Uttar Pradesh, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 31 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74999UP2017PTC095529. Its GSTIN is 08AAHCB3782C1ZR (Rajasthan). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Surendra and Manoj Singh.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Nagla Gheesa Khamani Goverdhan Road, Mathura, Uttar Pradesh, India – 281501.
As per the financials filed for FY 2022, the company reported a revenue of ₹38,763, a decline of 64% compared to the previous year. For the same year it recorded a net loss of ₹37,989 (net margin -98%) and EBITDA of -₹37,989 (EBITDA margin -98%). Revenue has declined at a compounded annual rate (CAGR) of 17% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Bluzin Pharmaceuticals Private Limited's registered office is in Mathura, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressNagla Gheesa Khamani Goverdhan Road, Mathura, Uttar Pradesh, India – 281501
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Bluzin Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bluzin Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Bluzin Pharmaceuticals Private Limited, buy the company report.
Financials of Bluzin Pharmaceuticals Private Limited
FY 2022 filings availableBluzin Pharmaceuticals Private Limited reported revenue of ₹38,763 (down 64% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 17% over three years, including a 64% fall in the latest year. EBITDA fell 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹38,763 | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹37,989 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹37,989 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -98% | ||||
| Net Profit Margin | -98% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bluzin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bluzin Pharmaceuticals Private Limited
Bluzin Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Surendra | Director | 31 Jul 2017 | 9 Years 2 Months | Current |
| Manoj Singh | Director | 31 Jul 2017 | 9 Years 2 Months | Current |
| Baijanti Nehra | Director | 08 Oct 2018 | 8 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Bluzin Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bluzin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bluzin Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAHCB3782C1ZR | Rajasthan | Active | 29 Oct 2018 |
To see the full GST registrations and return filing status of Bluzin Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bluzin Pharmaceuticals Private Limited has 3 board changes on record since 2017: 3 appointments. The latest: Baijanti Nehra was appointed as Director on 08 Oct 2018.
Frequently asked questions
Bluzin Pharmaceuticals is an active private limited company based in Mathura, Uttar Pradesh, India. The company works in other services, within the business services industry. It was incorporated on 31 July 2017 (9+ years old) and is registered under CIN U74999UP2017PTC095529.
Bluzin Pharmaceuticals has 3 current directors:
- Surendra - Director
- Manoj Singh - Director
- Baijanti Nehra - Director
The latest financial statements of Bluzin Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Bluzin Pharmaceuticals is 08AAHCB3782C1ZR, registered in Rajasthan. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Bluzin Pharmaceuticals is U74999UP2017PTC095529. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bluzin Pharmaceuticals was incorporated on 31 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Baijanti Nehra was appointed as Director on 08 Oct 2018. Manoj Singh was appointed as Director on 31 Jul 2017. Surendra was appointed as Director on 31 Jul 2017.
The registered office of Bluzin Pharmaceuticals is at Nagla Gheesa Khamani Goverdhan Road, Mathura, Uttar Pradesh, India – 281501.
Bluzin Pharmaceuticals operates in the business services industry, in the other services segment.
The compliance status of Bluzin Pharmaceuticals is compliant as of 19 August 2026. The company is actively filing with the Registrar of Companies.